Literature DB >> 9885780

Molecular genetics of substance abuse vulnerability: a current approach.

G R Uhl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9885780     DOI： 10.1016/S0893-133X(98)00061-X

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  10 in total

1.  Needed: mouse/human cross validation of reinstatement/relapse models (and drug reward models) to model human substance abuse vulnerability allelic variants.

Authors:  George R Uhl
Journal:  Psychopharmacology (Berl)       Date:  2003-04-29       Impact factor: 4.530

2.  Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.

Authors:  Jermaine D Jones; Rachel R Luba; Jonathan L Vogelman; Sandra D Comer
Journal:  Am J Addict       Date:  2015-12-21

3.  Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples.

Authors:  Qing-Rong Liu; Tomas Drgon; Donna Walther; Catherine Johnson; Oxanna Poleskaya; Judith Hess; George R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-09       Impact factor: 11.205

Review 4.  Molecular genetics of addiction vulnerability.

Authors:  George R Uhl
Journal:  NeuroRx       Date:  2006-07

Review 5.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

Review 6.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

7.  Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism.

Authors:  Catherine Johnson; Tomas Drgon; Qing-Rong Liu; Donna Walther; Howard Edenberg; John Rice; Tatiana Foroud; George R Uhl
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

Review 8.  What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

Authors:  Paul Cumming; Daniele Caprioli; Jeffrey W Dalley
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

9.  Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

Authors:  Jaime M Hatcher; Jason R Richardson; Thomas S Guillot; Alison L McCormack; Donato A Di Monte; Dean P Jones; Kurt D Pennell; Gary W Miller
Journal:  Exp Neurol       Date:  2007-01-05       Impact factor: 5.330

10.  Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.

Authors:  G R Uhl; Q R Liu; D Walther; J Hess; D Naiman
Journal:  Am J Hum Genet       Date:  2001-11-06       Impact factor: 11.025
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.